Institut Paoli-Calmettes
Head: Cell Therapy Facility, including cell collection and cell processing facilities, and Biological Resource Centre in Oncology
THE USE OF THE EBMT REGISTRY FOR FOLLOW-UP OF PATIENTS TREATED WITH IMMUNE EFFECTOR CELLS DERIVED THERAPEUTICS
October 15th
Jens Kastrup is clinical professor in Cardiovascular/Translational Medicine – Regenerative gene- and stem cell therapy within Cardiology at Rigshospitalet University of Copenhagen, Denmark. As clinical cardiologist, he established the Cardiology Stem Cell Centre, which is approved by the Danish Medicines...
En savoir +Dr. Emmanuel Donnadieu leads the team ‘Cancer and immune response’ at the Cochin Institute, INSERM, in Paris. Working in the field of Immunology for more than 15 years, he has accumulated a thorough experience in cell signalling and cellular imaging...
En savoir +Dr Suman Mitra completed his degree in Microbiology and received his PhD in Human Immunology. He then performed his postdoctoral training at the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda (USA). After several years working at the NIH...
En savoir +Since more than 20 years, I have been interested in the field of the T-cell response either after hematopoietic stem cell allo-transplantation or in the anti-tumor effect to modulate Graft versus Host disease (GvHD) or to initiate anti-tumoral effects (Graft...
En savoir +Mathieu Guerriaud is a Doctor of Pharmacy (PharmD) and a Doctor of Science (PhD). He is an associate professor in pharmaceutical law, pharmacovigilance and iatrogenesis, teaching at the Faculty of Health Sciences while working as a researcher in a law...
En savoir +A doctor in biology, the Bisontinental Inserm researcher worked for nearly ten years within Inserm's Joint Research Unit 1098 - hosted by the Etablissement français du sang Bourgogne-Franche-Comté, in Besançon - in the development of therapeutic approaches to control the...
En savoir +From the beginning of my career in 2001 at the “Etablissement Français du Sang” (EFS, BFC, Besançon), I became interested in translational research and more particularly to modulate the T cells lymphocyte response, such as T cells involved in host-graft-tumor...
En savoir +I studied Pharmacy in Tuebingen, did my PhD in Immunology, joined Miltenyi in 2003. There I started in the R&D Department, then changed to the Clinical Development department and now I´m Group Leader for T cell Immunotherapy in the Miltenyi...
En savoir +Jordan Gauthier is an Assistant Professor at the Fred Hutchinson Cancer Research Center (FHCRC) and the University of Washington in Seattle, WA. He was the first physician to be awarded the FHCRC Immunotherapy Integrated Research Center Fellowship Award. An expert...
En savoir +Marco Ruella, MD, is Assistant Professor of Medicine in the Division of Hematology/Oncology and the Center for Cellular Immunotherapies and Scientific Director of the Lymphoma Program at the Hospital of the University of Pennsylvania. His research focuses on the study...
En savoir +Nicolas Ferry is a M.D., Ph.D. His initial training in research was in endocrinology and pharmacology where he studies the regulation alpha adrenergic receptors in liver and blood platelets. During a post-doctoral stay at the Pasteur Institute in 1990, he...
En savoir +Director of the Cell Processing Facility and of the Cord Blood Bank of the University Hospital of Montpellier. Tenured Professor in Histology at the University Hospital Montpellier and University of Montpellier. My research group is focusing on the genetic stability...
En savoir +After an initial training in clinical hematology, I worked in an hematology intensive care and bone transplantation unit, then as a clinical consultant at the Besançon University hospital, France until 2009. I headed an immunogenetics laboratory from 1994 to 2004...
En savoir +Marcello Maresca is an Associate Director at AstraZeneca where he is currently leading the Precise Genome Editing team. In his role he supervises the strategy for the generation of advanced cellular and animal models of disease and for Therapeutic Genome...
En savoir +Christian Jorgensen is specialized in translational research for a better application of stem cells in immunology and rheumatology. He gathers scientists and clinicians on regenerative medicine and innovative immunotherapies. He has extensively published, has a strong track record for competitive...
En savoir +